XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Interim Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses        
Research and development $ 2,914 $ 1,307 $ 5,659 $ 2,464
General and administrative 3,340 1,446 5,915 1,988
Total operating expenses 6,254 2,753 11,574 4,452
Financing expense, net 480 17 264 22
Loss before taxes 6,734 2,770 11,838 4,474
Taxes on income (benefit) (544) 0 (544) 0
Net loss for the period $ 6,190 $ 2,770 $ 11,294 $ 4,474
Basic loss per Ordinary Share [1],[2] $ 0.027 $ 0.013 $ 0.05 $ 0.024
Diluted loss per Ordinary Share [1],[2] $ 0.027 $ 0.013 $ 0.05 $ 0.024
Weighted average number of Ordinary Shares outstanding, basic [1],[2] 228,173,276 216,266,993 228,132,249 186,840,022
Weighted average number of Ordinary Shares outstanding, diluted [1],[2] 228,173,276 216,266,993 228,132,249 186,840,022
[1] 20 Ordinary Shares are equal to 1 American Depositary Share (ADS).
[2] Number of shares has been retroactively adjusted to reflect the share reverse split effected on March 16, 2021 (refer to Note 1B).